Target N. V. Biotech Sells 1,279,820 Shares of Molecular Templates, Inc. (NASDAQ:MTEM) Stock

Molecular Templates, Inc. (NASDAQ:MTEM) major shareholder Target N. V. Biotech sold 1,279,820 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $0.66, for a total transaction of $844,681.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Molecular Templates Stock Down 3.9 %

Shares of NASDAQ:MTEM opened at $0.39 on Thursday. Molecular Templates, Inc. has a 12 month low of $0.30 and a 12 month high of $5.37. The company’s 50-day moving average price is $0.87 and its two-hundred day moving average price is $1.19. The firm has a market cap of $2.55 million, a P/E ratio of -0.14 and a beta of 1.22.

About Molecular Templates

Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).